A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2019; you can also visit the original URL.
The file type is application/pdf
.
MS3-1 IMPLEMENTATION OF GENE PANEL TESTING USING NEXT-GENERATION SEQUENCING
2019
Neuro-Oncology Advances
The advance of next-generation sequencers (NGS) has dramatically improved the performance of genomic analysis of clinical samples in cancer precision medicine. The practical use of gene panel testing for clinical applications has begun in Japan. At present, "OncomineTM Dx Target Test" is listed as a companion diagnostic system using NGS, and "FoundationOne CDx Cancer Genomic Profile" and "OncoGuide™ NCC Oncopanel System" are listed as gene panel testing under insurance coverage. Formalin-fixed
doi:10.1093/noajnl/vdz039.011
fatcat:t3s3tlhwqnhwpiqsozyeqj2uxi